Skip to main content
Equibles
IMCR logo

IMCR · Immunocore Holdings plc · Webcasts, Transcripts & Audio

Track IMCR — free

Use IMCR with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research IMCR.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$29.59 -0.12 (-0.40%)
Rebalance outlook locked
Market Cap
$1.58B
Shares
51.50M
Volume · Oct 5 329.45K Avg daily vol (3M) 456.79K

Immunocore Holdings plc Webcasts

Earnings calls, investor updates, investor days and conferences for Immunocore Holdings plc (IMCR), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
· $59.76M −$17.01M '23 Q2 23-06-30 · $70.16M −$19.73M '23 Q4 24-01-29 ▲26.2% $75.40M −$11.62M '24 Q2 24-08-08 ▲19.8% $84.05M −$23.77M '24 Q4 25-01-10 ▲29.9% $97.96M −$10.30M '25 Q2 25-08-07 ▲24.3% $104.48M −$30.06M '25 Q4 26-02-25 LATEST ▲18.3% $115.93M −$808,000 '26 Q2 26-08-06
Earnings call
FY26 · Q2
2026-08-06
Immunocore Holdings plc (IMCR) Q2 2026 Earnings Call
Revenue
$115.93M
▲ 18.3% YoY
Diluted EPS
$-0.02
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Annual General Meeting
Investor event
2026-05-27
Immunocore Holdings plc (IMCR) May 2026 Annual General Meeting
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-04-13
Immunocore Holdings plc (IMCR) April 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q4
2026-02-25
Immunocore Holdings plc (IMCR) Q4 2025 Earnings Call Transcript
Confident tone KIMTRAK commercial performance Cutaneous melanoma opportunity Pipeline expansion and Phase 3 trials
Revenue
$104.48M*
▲ 24.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q2
2025-08-07
Immunocore Holdings plc (IMCR) Q2 2025 Earnings Call Transcript
Confident tone TEBE-AM Phase III in second-line cutaneous melanoma KIMMTRAK commercial performance and global expansion Autoimmune pipeline expansion (T1D, second program)
Revenue
$97.96M
▲ 29.9% YoY
Diluted EPS
$-0.20
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-01-10
Immunocore Holdings plc (IMCR) Q4 2024 Earnings Call Transcript
Confident tone KymTrah commercial performance and growth Infectious disease pipeline (HIV / HBV) Autoimmune programs
Revenue
$84.05M*
▲ 19.8% YoY
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q2
2024-08-08
Immunocore Holdings plc (IMCR) Q2 2024 Earnings Call Transcript
Positive tone Pipeline and clinical readouts KIMMTRAK commercial performance European reimbursement challenges
Revenue
$75.40M
▲ 26.2% YoY
Diluted EPS
$-0.23
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-01-29
Immunocore Holdings plc (IMCR) Q4 2023 Earnings Call Transcript
Confident tone PRAME franchise (F106C, PRISM-MEL301) KIMMTRAK commercial performance TEBE-AM Phase 2/3 trial in cutaneous melanoma
Revenue
$70.16M*
Rev · 3q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q2
2023-06-30
Immunocore Holdings plc (IMCR) Q2 2023 Earnings Call Transcript
Revenue
$59.76M
Diluted EPS
$-0.35
Rev · 2q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
Immunocore Holdings plc (IMCR) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q2
2022-06-30
Immunocore Holdings plc (IMCR) Q2 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Showing 1–11 of 11 webcasts
Key facts CIK 1671927 CUSIP 45258D105 13F (30d) 2 filings 2 filers Visit website Investor relations